相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The genetic architecture of Parkinson's disease
Cornelis Blauwendraat et al.
LANCET NEUROLOGY (2020)
The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson's disease
B. R. Bloem et al.
BMC NEUROLOGY (2019)
Resting-state fMRI in Parkinson's disease patients with cognitive impairment: A meta-analysis
Amee F. Wolters et al.
PARKINSONISM & RELATED DISORDERS (2019)
Monitoring Parkinson's disease symptoms during daily life: a feasibility study
Margot Heijmans et al.
NPJ PARKINSONS DISEASE (2019)
Genetic risk of Parkinson disease and progression: An analysis of 13 longitudinal cohorts (vol 5, e348, 2019)
H. Iwaki et al.
NEUROLOGY-GENETICS (2019)
Towards remote monitoring of Parkinson's disease tremor using wearable motion capture systems
Mehdi Delrobaei et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Comparison of clinical features among Parkinson's disease subtypes: A large retrospective study in a single center
Takuya Konno et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
High-resolution in vivo imaging of human locus coeruleus by magnetization transfer MRI at 3T and 7T
Nikos Priovoulos et al.
NEUROIMAGE (2018)
Individualized parcellation of the subthalamic nucleus in patients with Parkinson's disease with 7T MRI
Birgit R. Plantinga et al.
NEUROIMAGE (2018)
Using Wearable Technology to Generate Objective Parkinson's Disease Dyskinesia Severity Score: Possibilities for Home Monitoring
Mehdi Delrobaei et al.
IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING (2017)
Neuromelanin MRI is useful for monitoring motor complications in Parkinson's and PARK2 disease
Taku Hatano et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
The Role of High-Field Magnetic Resonance Imaging in Parkinsonian Disorders: Pushing the Boundaries Forward
Stephane Lehericy et al.
MOVEMENT DISORDERS (2017)
Epigenetic Biomarkers for Parkinson's Disease: From Diagnostics to Therapeutics
Jennifer L. Jakubowski et al.
JOURNAL OF PARKINSONS DISEASE (2017)
BIDS apps: Improving ease of use, accessibility, and reproducibility of neuroimaging data analysis methods
Krzysztof J. Gorgolewski et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
Home detection of freezing of gait using support vector machines through a single waist-worn triaxial accelerometer
Daniel Rodriguez-Martin et al.
PLOS ONE (2017)
Comparison of T2*-weighted and QSM contrasts in Parkinson's disease to visualize the STN with MRI
Anneke Alkemade et al.
PLOS ONE (2017)
Ultra high-field SWI of the substantia nigra at 7T: reliability and consistency of the swallow-tail sign
Manuel A. Schmidt et al.
BMC NEUROLOGY (2017)
Resting-state functional reorganization in Parkinson's disease: An activation likelihood estimation meta-analysis
Masoud Tahmasian et al.
CORTEX (2017)
Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression
Seyed-Mohammad Fereshtehnejad et al.
BRAIN (2017)
The role of magnetic resonance imaging in the diagnosis of Parkinson's disease: a review
Ali M. Al-Radaideh et al.
CLINICAL IMAGING (2016)
The first step for neuroimaging data analysis: DICOM to NIfTI conversion
Xiangrui Li et al.
JOURNAL OF NEUROSCIENCE METHODS (2016)
New methods for the assessment of Parkinson's disease (2005 to 2015): A systematic review
Alvaro Sanchez-Ferro et al.
MOVEMENT DISORDERS (2016)
Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With 123I-FP-CIT SPECT
Yun Jung Bae et al.
MOVEMENT DISORDERS (2016)
Loss of substantia nigra hyperintensity on 7 Tesla MRI of Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy
Jong-Min Kim et al.
PARKINSONISM & RELATED DISORDERS (2016)
Longitudinal changes in free-water within the substantia nigra of Parkinson's disease
Edward Ofori et al.
BRAIN (2015)
Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study
Elijah Mak et al.
BRAIN (2015)
Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism
Eva Reiter et al.
MOVEMENT DISORDERS (2015)
Automated Neuromelanin Imaging as a Diagnostic Biomarker for Parkinson's Disease
Gabriel Castellanos et al.
MOVEMENT DISORDERS (2015)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
Longitudinal midbrain changes in early Parkinson's disease: Iron content estimated from R2*/MRI
Marguerite Wieler et al.
PARKINSONISM & RELATED DISORDERS (2015)
Prioritized Research Recommendations from the National Institute of Neurological Disorders and Stroke Parkinson's Disease 2014 Conference
Beth-Anne Sieber et al.
ANNALS OF NEUROLOGY (2014)
Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease (QUIP) and the QUIP-rating scale in a German speaking sample
Catharina Claudia Probst et al.
JOURNAL OF NEUROLOGY (2014)
The Parkinson Anxiety Scale (PAS): Development and Validation of a New Anxiety Scale
Albert F. G. Leentjens et al.
MOVEMENT DISORDERS (2014)
The 'Swallow Tail' Appearance of the Healthy Nigrosome - A New Accurate Test of Parkinson's Disease: A Case-Control and Retrospective Cross-Sectional MRI Study at 3T
Stefan T. Schwarz et al.
PLOS ONE (2014)
MR Imaging of the Substantia Nigra at 7 T Enables Diagnosis of Parkinson Disease
Mirco Cosottini et al.
RADIOLOGY (2014)
Parkinson Disease Subtypes
Mary Ann Thenganatt et al.
JAMA NEUROLOGY (2014)
Differential and distributed effects of dopamine neuromodulations on resting-state network connectivity
David M. Cole et al.
NEUROIMAGE (2013)
Is R2* a New MRI Biomarker for the Progression of Parkinson's Disease? A Longitudinal Follow-Up
Miguel Ulla et al.
PLOS ONE (2013)
Dopamine Supports Coupling of Attention-Related Networks
Linh C. Dang et al.
JOURNAL OF NEUROSCIENCE (2012)
Quantitative assessment of the effects of high-permittivity pads in 7 Tesla MRI of the brain
Wouter M. Teeuwisse et al.
MAGNETIC RESONANCE IN MEDICINE (2012)
SA2RAGE: A new sequence for fast B1+-mapping
Florent Eggenschwiler et al.
MAGNETIC RESONANCE IN MEDICINE (2012)
Automated Assessment of Bradykinesia and Dyskinesia in Parkinson's Disease
Robert I. Griffiths et al.
JOURNAL OF PARKINSONS DISEASE (2012)
The Parkinson Progression Marker Initiative (PPMI)
Kenneth Marek et al.
PROGRESS IN NEUROBIOLOGY (2011)
Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease
Claire L. Tomlinson et al.
MOVEMENT DISORDERS (2010)
Determination of the Longitudinal Validity and Minimally Important Difference of the 8-item Parkinson's Disease Questionnaire (PDQ-8)
Nan Luo et al.
MOVEMENT DISORDERS (2009)
Parkinson's disease: clinical features and diagnosis
J. Jankovic
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results
Christopher G. Goetz et al.
MOVEMENT DISORDERS (2008)
The REM sleep behavior disorder screening questionnaire -: A new diagnostic instrument
Karin Stiasny-Kolster et al.
MOVEMENT DISORDERS (2007)
G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences
Franz Faul et al.
BEHAVIOR RESEARCH METHODS (2007)
Reliability and validity of the Beck Depression Inventory in patients with Parkinson's disease
M Visser et al.
MOVEMENT DISORDERS (2006)
Movement disorder society task force report on the Hoehn and Yahr staging scale: Status and recommendations
CG Goetz et al.
MOVEMENT DISORDERS (2004)
Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA-AUT
M Visser et al.
MOVEMENT DISORDERS (2004)
The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service
AJ Hughes et al.
BRAIN (2002)
分享论文
